MedTrace Logo

Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis

NCT04791202 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2021-03-16

No results posted yet for this study

Summary

The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early osteoarthritis by corticosteroids by giving long standing effect and improving patients' symptoms and function. Over the past 5 years, an increasing number of level I and level II studies have emerged, examining the effect of intra-articular prolotherapy for the treatment of both hip and knee osteoarthritis. On the contrary, there is limited data in small joints, such as the temporomandibular joint.

Conditions

  • Pain
  • Satisfaction, Patient
  • Functionality

Interventions

DRUG

Dextrose

See arm descriptions

DRUG

Methylprednisolone Acetate 40 MG/ML

See arm descriptions

Sponsors & Collaborators

  • Kleinert, Kutz and Associates

    collaborator OTHER

  • Christine M. Kleinert Institute for Hand and Microsurgery

    lead OTHER

Principal Investigators

  • Tuna Ozyurekoglu, MD · President

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-03-01
Completion
2022-07-01
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04791202 on ClinicalTrials.gov